Webinar: Discussion of 6-month MDR-TB treatment - recording now available online

RESIST-TB conducted a webinar on 14 April 2022 on the latest results in the recent studies reporting on pretomanid-containing regimens, ZeNiX and TB-PRACTECAL, for the treatment of multidrug-resistant TB (MDR-TB).

Video recording of the webinar is now available online and can be accessed here.

To subscribe to the Weekly Newsletter of new posts, enter your email here:


News

By RESIST-TB

Published: April 17, 2022, 10:13 p.m.

Last updated: April 25, 2022, 9:15 p.m.

Print Share